An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy

In conclusion, this intravascular ultrasound study suggests that treatment of cardiac transplant recipients with either ACE inhibitors or CEBs is associated with a decrease in the degree of vascular intimal hyperplasia at 1 year after transplantation. Thus, early intervention with CEBs or ACE inhibitors offers a preventive option for the devastating consequences of cardiac allograft vasculopathy.